Efficacy of BLIS K12 as Preventive Measure for Rheumatic Children

Key facts

Sponsor

Kaplan Medical Center

Principal Investigator

Yael Garty, MD

Attending physician

Intervention

Streptococcus Salivarius BLIS K12(dietary_supplement)

Enrollment

30 target

Eligibility

6-16 years · All sexes

Timeline

2015

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Rheumatic fever

Additional recruiting or active studies for the same condition.

• RECRUITINGPHASE3NCT06259006
  TREAT-SC: Early, Short Course Oral Dexamethasone for the Treatment of Sydenham Chorea in Children
  Starship Child Health, Te Toka Tumai Auckland
• RECRUITINGNANCT06400628
  Effectiveness of Chronic Self-management Education on Behavioral and Clinical Outcomes
  Jimma University

See all trials for Rheumatic fever →